Invention Grant
- Patent Title: Antibody molecules to LAG-3 and uses thereof
-
Application No.: US15469096Application Date: 2017-03-24
-
Publication No.: US09908936B2Publication Date: 2018-03-06
- Inventor: Frédéric Triebel , Chrystelle Brignone , Walter A. Blattler , Jennifer Marie Mataraza , Catherine Anne Sabatos-Peyton , Hwai Wen Chang , Gerhard Johann Frey
- Applicant: Novartis AG , Immutep S.A.S.
- Applicant Address: CH Basel FR Orsay
- Assignee: Novartis AG,Immutep S.A.S.
- Current Assignee: Novartis AG,Immutep S.A.S.
- Current Assignee Address: CH Basel FR Orsay
- Agency: Lando & Anastasi, LLP
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
Antibody molecules that specifically bind to LAG-3 are disclosed. The anti-LAG-3 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious disorders.
Public/Granted literature
- US20170210804A1 ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF Public/Granted day:2017-07-27
Information query
